Morning Headlines 1/3/19
Health Level Seven International publishes the FHIR Release 4 standard.
Bristol-Myers Squibb to buy Celgene in $74 billion deal
The merger, if approved by shareholders and regulators, will create the US’s fourth-largest drug company.
Healthcare AI vendor Jvion raises a growth equity investment of an unstated amount, led by JMI Equity.
The news about AHRQ is very unfortunate. The AHRQ staff were always excellent to collaborate with. They had an impressive…